Public Health

Cancer Lobbyists Unite to Overcome Political Divides
Clinical & Pharma Cancer Lobbyists Unite to Overcome Political Divides

Today, we’re speaking with James Maitland, a renowned expert in robotics and IoT applications in medicine, who brings a unique perspective to the intersection of technology and healthcare. With a deep passion for improving patient outcomes through innovation, James has been following the impactful

Neuroblastoma in Spain: Stable Rates, Rising Survival Over 22 Years
Clinical & Pharma Neuroblastoma in Spain: Stable Rates, Rising Survival Over 22 Years

In a groundbreaking examination spanning over two decades, a comprehensive study conducted from 2000 to 2021 has unveiled critical insights into the landscape of neuroblastoma among children in Spain, focusing on those under 15 years of age. This pediatric cancer, recognized as the most common

How Are Trump Funding Cuts Impacting UC Medical Research?
Clinical & Pharma How Are Trump Funding Cuts Impacting UC Medical Research?

In the heart of California, where innovation often leads the charge against life-threatening diseases, a chilling uncertainty grips the University of California (UC) medical research community as federal funding, the very lifeline of groundbreaking studies at campuses like UCLA, has been frozen by

Can Geriatrics Training Survive Funding Uncertainty?
Clinical & Pharma Can Geriatrics Training Survive Funding Uncertainty?

I'm thrilled to sit down with James Maitland, a renowned expert in geriatrics and healthcare policy, whose extensive work has shaped innovative approaches to training healthcare providers for an aging population. With a deep understanding of programs like the Geriatrics Workforce Enhancement

How Does Vici Syndrome Link to Parkinson’s Disease?
Clinical & Pharma How Does Vici Syndrome Link to Parkinson’s Disease?

In a remarkable stride forward in medical research, a recent study published in the Annals of Neurology on October 8, 2025, has unveiled a profound genetic connection between Vici syndrome, a rare childhood neurodevelopmental disorder, and Parkinson’s disease, a condition typically associated with

2025 Nobel Prize: Breakthrough in Immune Tolerance Research
Clinical & Pharma 2025 Nobel Prize: Breakthrough in Immune Tolerance Research

In a landmark moment for medical science, the Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their transformative discoveries in peripheral immune tolerance, a critical mechanism that ensures the immune system safeguards the body

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later